Evaluating the viral clearance ability of continuous monoclonal antibody purification steps, in order to inactivate and/or remove four model viruses

BACKGROUND AND OBJECTIVES: Viral clearance studies are an essential part of a manufacturer’s plan to ensure the safety of an injectable biologic product. In this way, viral safety is a critical quality attribute for biologics such as monoclonal antibodies (Mabs). Evaluation of virus purification by...

Descripción completa

Detalles Bibliográficos
Autores principales: Rasouli-Nejad Mousavi, Seyed Mohammad, Hosseini, Seyed Masoud, Ansari, Samira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628082/
https://www.ncbi.nlm.nih.gov/pubmed/37941874
http://dx.doi.org/10.18502/ijm.v15i5.13877

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628082/
https://www.ncbi.nlm.nih.gov/pubmed/37941874
http://dx.doi.org/10.18502/ijm.v15i5.13877

Ejemplares similares